Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital
Clinical trial NCT06922643 · COMPLETED
Trial details
- NCT number
- NCT06922643
- Sponsor
- Nanogen Pharmaceutical Biotechnology Joint Stock Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-01-21
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.